Mobius Therapeutics mobiustherapeutics.com


Public lists: Eye Health (703)

Mobius Therapeutics is a commercial stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. The glaucoma indication is in active commercialization; the pterygium and refractive indications are awaiting approval by the Food and Drug Administration.

Mobius Therapeutics is a commercial stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. The glaucoma indication is in active c...Show all

Company (Alive / Active)

Phone: 314-615-6930

Fax:

4041 Forest Park Avenue

St. Louis, 63108
Missouri, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mobius Therapeutics $7.6M Oct 11, 2013
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mobius Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

EnteroMedics

Saint Paul, Minnesota, United States
IPO / Went publicEnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a first-in-class weight loss treatment that addresses the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. vBloc® Therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System controls both hunger and fullness by bloc...Show allLogin to see details

PulmonX

Redwood City, California, United States
Alive / ActivePulmonX designs and manufactures products to deliver endoscopic lung volume reduction (ELVR) to patients with emphysema-induced hyperinflation. ELVR involves placing small one-way valves in the lung to prevent air from entering the most diseased regions while allowing secretions and trapped air to escape. The goal is to reduce the volume of the diseased portions of the lung to allow increased ventilation to healthier areas of the lung, thereby achieving the benefits of surgical lung volume reduc...Show allLogin to see details
See all 16 competitors